The main market opportunities lie in the commercialization and development of PSMA-targeted therapies and radiodiagnostics for prostate cancer. Key areas include expansion in radioligand therapy and ...

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

Long-term safety of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC): 7-year follow-up from the largest global prospective study. Multivariable analysis of factors ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

Vascular-targeted photodynamic therapy continues to shows efficacy for partial gland ablation of intermediate-risk prostate cancer with minimal toxicity, according to long-term follow-up results from ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

You are at the center of everything we do at the Prostate Oncology Center at Fred Hutchinson Cancer Center. Here, we surround you with a team of specialists who work together closely to provide expert ...